Internal Medicine, Rheumatology · Houston, TX
NPI
1295728590
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
902 Frostwood Dr, Ste 307
Houston, TX, 77024
Phone (713) 467-7704
Medicare paid, 2024
$63K
511 services
Medicare patients, 2024
79
Average age 73
Drug cost, 2024
$1.5M
4,021 prescriptions
Company payments, 2025
$269
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David E Burns was code 99215 (office e&m - established), 499 times for 77 patients. In total David E Burns billed 511 services in 4 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 499 | 77 | $123.22 | $61K |
By year: 2022 $60K for 481 services; 2023 $64K for 519 services; 2024 $63K for 511 services.
Medicare prescription drug claims, 2024
In 2024, the drug David E Burns prescribed most often to Medicare patients was Levothyroxine Sodium, with 210 prescriptions and refills. In total David E Burns wrote 4,021 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 210 | 598 | 66 | $2,614 |
| Liothyronine Sodium Generic | 197 | 577 | 67 | $8,163 |
| Allopurinol Generic | 162 | 456 | 48 | $2,006 |
| Methylprednisolone Generic | 158 | 347 | 60 | $5,570 |
| Leflunomide Generic | 140 | 330 | 45 | $7,095 |
| Balsalazide Disodium Generic | 131 | 372 | 40 | $19K |
| Mesalamine Generic | 121 | 317 | 42 | $86K |
| Mycophenolate Mofetil Generic | 109 | 280 | 27 | $12K |
| Omeprazole Generic | 108 | 322 | 34 | $2,203 |
| Sulfasalazine Generic | 105 | 287 | 32 | $2,038 |
| Mounjaro Tirzepatide | 92 | 115 | 14 | $123K |
| Torsemide Generic | 84 | 224 | 28 | $1,464 |
| Pantoprazole Sodium Generic | 84 | 215 | 28 | $1,568 |
| Montelukast Sodium Generic | 77 | 225 | 25 | $789 |
| Hydroxychloroquine Sulfate Generic | 68 | 186 | 24 | $3,807 |
Brand drugs: - claims; generic drugs: 3,292 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David E Burns $269 ($269 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $115.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.